ES
Therapeutic Areas
Vortex Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VTX-1 Liquid Biopsy System | Cancer Research & Monitoring | Commercial (RUO) |
| Clinical Study for Cancer Monitoring | Cancer Treatment Response | Clinical Validation |
Leadership Team at Vortex Biosciences
NB
Nigel Brooksby
Non Executive Chairman
PR
Paul Reeves
Managing Director
II
Ilian Iliev, PhD
Investor Director & Board Member
JH
Jacqueline Hall, PhD
VP Offering Development
JM
John Matthews
VP Clinical Operations
CT
Colin Toombs
Technical Advisor